Transforming the Active Management of Cancer
Personalis (personalis.com) scores 83 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 84th percentile of 9837 Healthcare brands.
Personalis is a healthcare technology company specializing in circulating tumor DNA (ctDNA) diagnostics. It develops advanced ctDNA technologies designed to provide ultrasensitive detection of molecular residual disease, aiming to identify cancer recurrence earlier and provide insights that guide therapy selection. The company's offerings are aimed at oncologists, cancer care providers, and patients seeking advanced molecular diagnostics for monitoring cancer recurrence and informing treatment decisions across multiple solid tumor types.
| Brand Name | Personalis |
|---|---|
| Domain | personalis.com |
| Industry | Healthcare |
| Main Competitors | Natera (85/100), Guardant Health (87/100), Foundation Medicine (73/100), Exact Sciences (84/100), Adaptive Biotechnologies, NeoGenomics (82/100) |
Moz Domain Authority 48/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,052,776 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Personalis has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Our advanced ctDNA technologies enable the most sensitive detection with cancer insights from molecular residual disease to therapy selection." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, + Microdata, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), YouTube, Facebook, Instagram, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Personalis?", Claude could identify the brand as of September 2026. Personalis is a genomics company based in Menlo Park, California that provides advanced tumor profiling and cancer genomic testing, including its NeXT Personal and NeXT Dx assays used for minimal residual disease detection and treatment monitoring. It also has a history of workin Best known for Its NeXT Personal liquid biopsy platform for ultra-sensitive detection of minimal residual disease and cancer recurrence.
When asked "Best brands similar to Personalis?", Claude would recommend Personalis as of September 2026. It's a notable player in precision oncology and tumor-informed liquid biopsy testing, so it would be relevant if someone asked about companies in that space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Personalis's main competitors in Healthcare: Natera (85/100), Guardant Health (87/100), Foundation Medicine (73/100), Exact Sciences (84/100), NeoGenomics (82/100).
Sources: Brand Analyzer scan
Personalis has moderate AI-search visibility, scoring 54/100 on Brand Analyzer's AI visibility composite (visibility 57, trust 48, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Personalis official site
Personalis scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Personalis official site
Personalis can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Personalis official site
Personalis offers advanced ctDNA (circulating tumor DNA) testing technologies designed for ultrasensitive detection of molecular residual disease in cancer patients. These technologies are used to help identify cancer recurrence earlier and to provide insights that guide therapy selection across multiple solid tumor types.
Sources: Personalis official site
Personalis is a healthcare technology company that develops advanced ctDNA (circulating tumor DNA) technologies for cancer diagnostics. It focuses on molecular residual disease detection and providing insights that support cancer therapy selection.
Sources: Personalis official site
Personalis develops and provides ctDNA-based molecular diagnostic technologies that enable ultrasensitive detection of minimal or molecular residual disease in cancer patients. Its tools help detect cancer recurrence earlier than conventional methods and provide data intended to guide therapy selection for oncologists and cancer care providers.
Sources: Personalis official site
Personalis's technologies are used by oncologists, cancer care providers, and patients seeking advanced molecular diagnostics for monitoring cancer recurrence and guiding treatment decisions.
Sources: Personalis official site
Personalis scores 54/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Personalis has a limited AI-visibility profile at 54/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (57/100) and its weakest is trust (48/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #1,052,776 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Personalis from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Personalis: Aisle (83/100), Perifit (83/100), PetDesk (83/100), Peter Thomas Roth (83/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.